The global breast localization system market is estimated to create an incremental opportunities of more than US$ 1 Bn by 2022, exhibiting growth at a CAGR of 9% to 10% during the forecast period 2022-2032. The demand for breast localization systems are expected to reach US$ 2 Bn by the end of 2032, in comparison to the US$ 990 Mn registered in 2021.
| Report Attribute | Details |
| Breast Localization System Market Base Year Value (2021) | US$ 990 Million |
| Breast Localization System Market Expected Value (2022) | US$ 1 Billion |
| Breast Localization System Market Anticipated Value (2032) | US$ 2 Billion |
| Breast Localization System Market Projected Growth Rate (2022-2032) | 9% to 10% CAGR |
Breast localization systems are medical devices used to locate breast abnormalities that cannot be felt but can be seen on the mammogram. These medical devices are gaining huge traction across the breast diagnostics infrastructures, owing to favorable attributes such as precision localization, high accuracy, ease of use, and others.
Due to the rise in alcohol consumption, smoking, obesity, radiation exposure, and others, a substantial rise in prevalence of breast cancer is being witnessed across the globe, resulting in bolstering the demand for assistive devices for diagnosis and treatment.
For instance, according to a study by the World Health Organization (WHO), around 7.8 Mn women are leaving with breast cancer worldwide and nearly 2.3 Mn were women were newly diagnosed with cancer in the year 2020. As breast localization systems are extensively used in medical procedures such as breast biopsy and lumpectomy for both benign & malignant breast tumors, growing burden of breast cancer is projected to create lucrative opportunities for growth in the market.
Despite several benefits related to the use of breast localization systems, extravagant cost of procedures, high cost of these medical devices, need for qualified professionals, and uncertainty in results are some of the factors hindering the sales in the market.
Also, the presence of strict regulatory approval standards and policies across countries such as the U.S., the U.K., Germany, India, and China among others are restraining the growth in the global breast localization system market.
North America is forecast to emerge as the most lucrative market for breast localization systems between 2022 and 2032, as per Future Market Insights.
With growing consumer spending on enhancing body aesthetics and rising adoption of cosmetics surgical procedures for increasing the size of body parts, a swift rise in number of breast augmentation procedures is being witnessed across North America. For instance, according to the America Society of Plastic Surgeons, around 193,073 breast augmentation surgeries were registered across the U.S. alone in the year 2020.
As breast localization systems such as guided wires, radioisotope, magnetic tracers, and others are used before and after these procedures for diagnosis, growing breast augmentation surgeries are estimated to augment the demand in North America.
FMI reveals that Europe is projected to account for a significant share in the global breast localization systems market during the forecast period 2022-2032.
Demand for breast localization systems is rapidly increasing across Europe, driven by the growing burden of breast cancer, increasing breast biopsies, rising adoption of augmentation surgeries.
This, in addition to growing advancements in magnetic and radioisotopes technology, leading players in the market are emphasizing on launching novel products integrated with advanced high precision technologies to cater to growing demand. Such developments and new product launches are anticipated to facilitate the growth in the Europe market.
Some of the leading players in the breast localization system market are Ranfac Corporation, C.R. Bard, Invivo Corporation, SOMATEX Medical Technologies GmbH, SurgicEye GmbH, Cianna Medical, Cook Medical, GE Healthcare, Argon Medical Devices, Intra-Medical Imaging LLC, IsoAid, LLC, NuclearLab S.R.L. and Endomagnetics Ltd. among others.
The market for breast localization system is highly competitive, attributed to large pool of market participant and growing emphasis on the launch of novel products with innovative features and technologies.
| Report Attribute | Details |
| Growth Rate | CAGR of 9% to 10% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Countries Covered |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By Device Type:
By Application:
By End User:
By Region:
FMI projects the sales of breast localization system in the market is expected to rise at 9% to 10% value CAGR by 2032
The global breast localization system market is expected to be dominated by North America over the forecast period 2022-2032.
Ranfac Corporation, C.R. Bard, Invivo Corporation, SOMATEX Medical Technologies GmbH, SurgicEye GmbH, Cianna Medical, Cook Medical, GE Healthcare, Argon Medical Devices, Intra-Medical Imaging LLC, IsoAid, LLC, NuclearLab S.R.L. and Endomagnetics Ltd., others are some of the leading players in the key breast localization system market.
Explore Similar Insights
Breast Localization System Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
